FDA Inspection 1226820 — Nina Magnolo, MD, Clinical Investigator

Nina Magnolo, MD, Clinical Investigator — FEI 3028442075

The FDA completed an inspection of Nina Magnolo, MD, Clinical Investigator on Dec 1, 2023 in Munster. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 1, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Munster (Germany)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.